The pharmaceutical industry swears the high cost of drugs is due to research and development costs, conveniently omitting the actual amount of money spent on the marketing of these drugs, which is exorbitantly more. A recent Deloitte report suggests that pharmaceutical companies are taking a hit because investments made in R&D on new drugs simply are not paying off anymore. [1]
Soon you may lose the freedom to refuse medical procedures.
Large-scale political and economic challenges are confronting the US multi-national corporate elite. Apple, Google, Facebook, Microsoft, Pfizer and scores of other multinational tax evaders are facing the triple threat of multi-billion dollar fines, the redistribution of their wealth and the possible reintroduction of equitable socio-economic programs, which could undermine their power.
This week on #NewWorldNextWeek: Bilderberg is now implanting propaganda in their press releases; Brexit looms as EU popularity plummets; and Muhammad Ali might end selective service from beyond the grave.
This week on #NewWorldNextWeek: Bilderberg is now implanting propaganda in their press releases; Brexit looms as EU popularity plummets; and Muhammad Ali might end selective service from beyond the grave.
Last week, a St. Louis Circuit Court jury awarded $46.5 million to 3 plaintiffs who alleged that PCBs made by Monsanto caused cancer. The plaintiffs alleged in the suit that Monsanto and the other defendants – Solutia, Pharmacia, and Pfizer – were negligent in their handling of PCBs.
(ANTIMEDIA) U.S. firm Pfizer officially withdrew from t […]
The post Pharmaceutical Giant Just Declared War on the Death Penalty appeared first on The Anti-Media.
Monsanto tried to buy-out one of its biggest competitors on the biotech scene with a $46 billion bid – it was for Syngenta. Then Monsanto tried to acquire Bayer Crop Sciences. But after the company’s recent dismal stock earnings report, the CEO says that big deals are out.
As Washington cracks down on pharmaceutical company greed, the largest ever health-care-acquisition between Allergan and Pfizer has been dissolved.
Pfizer will have to pay Allergan $400 million in fees for pulling out of the planned $160 billion merger, but the mega-pharmaceutical company will end up paying much more in avoided taxes.
Pill pushers, chocolate slaves and fat earthers + this day in history w/Celluloid and our song of the day by The Jayhawks on your Morning Monarchy for April 6, 2016.
